At a glance
ClinicalIndex Comparison RecordN/ACompleted· 98 enrolled
Drug / intervention
Virtue® Male Incontinence Slingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Virtue® Male Incontinence Sling Study
In Brief
A clinical study evaluating Virtue® Male Incontinence Sling for Stress Urinary Incontinence. Completed, enrolled 98 participants across 11 sites in 2 countries.
Detailed Summary
This study is a multi-center, global study that will assess the effectiveness and patient satisfaction of the male incontinence sling 12 months after implant as well as the safety profile of the product.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress Urinary Incontinence
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedMar 2009
Primary CompletionJan 2011
TodayJul 2026
First PostedMar 6, 2009
Enrollment StartJan 1, 2009
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.3 years ago
Interventions
Virtue® Male Incontinence Slingdevice
The VIRTUE® male sling is a Class II, implantable, sub-urethral, permanent, non-absorbable support sling indicated for the surgical treatment of male SUI resulting from intrinsic sphincter deficiency. The sling is manufactured from polypropylene and is sold for single use only.